NASDAQ:OPRX • US68401U2042
The current stock price of OPRX is 8.63 USD. In the past month the price decreased by -25.99%. In the past year, price increased by 49.31%.
ChartMill assigns a technical rating of 1 / 10 to OPRX. When comparing the yearly performance of all stocks, OPRX turns out to be only a medium performer in the overall market: it outperformed 48.94% of all stocks.
ChartMill assigns a fundamental rating of 6 / 10 to OPRX. OPRX has only an average score on both its financial health and profitability.
Over the last trailing twelve months OPRX reported a non-GAAP Earnings per Share(EPS) of 0.82. The EPS increased by 182.76% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 0.03% | ||
| ROA | 0.02% | ||
| ROE | 0.03% | ||
| Debt/Equity | 0.2 |
13 analysts have analysed OPRX and the average price target is 24.82 USD. This implies a price increase of 187.6% is expected in the next year compared to the current price of 8.63.
For the next year, analysts expect an EPS growth of 131.3% and a revenue growth 19.98% for OPRX
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| VEEV | VEEVA SYSTEMS INC-CLASS A | 20.85 | 30.011B | ||
| WAY | WAYSTAR HOLDING CORP | 15.62 | 4.934B | ||
| DOCS | DOXIMITY INC-CLASS A | 14.41 | 4.66B | ||
| HTFL | HEARTFLOW INC | N/A | 2.043B | ||
| CCLDO | CARECLOUD INC - CCLD 8 3/4 PERP | 229.95 | 1.094B | ||
| LFMDP | LIFEMD INC - LFMD 8 7/8 PERP | N/A | 1.093B | ||
| CERT | CERTARA INC | 11.98 | 1.059B | ||
| SDGR | SCHRODINGER INC | N/A | 875.817M | ||
| TDOC | TELADOC HEALTH INC | N/A | 865.468M | ||
| GDRX | GOODRX HOLDINGS INC-CLASS A | 5.35 | 801.055M |
View all stocks in the Health Care Technology Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find more growth stocks the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
OptimizeRx Corp. is digital health company, engaged in the provision of digital health messaging via electronic health records, which serve as a direct channel for pharmaceutical companies to communicate with healthcare providers. The company is headquartered in Waltham, Massachusetts and currently employs 106 full-time employees. The company went IPO on 2005-05-18. The Company’s platform combines artificial intelligence (AI)-driven tools like the Dynamic Audience Activation Platform (DAAP) and Micro-Neighborhood Targeting (MNT) to deliver timely, relevant, and hyper-local engagement. Its DAAP generates dynamic audiences with predictive analytics via machine learning methods. MNT creates consumer audiences using a privacy-first process. Its principal solutions include Audience Development: DAAP and MNT, Audience Profiling: Profiler, Audience Activation and Media Execution, Pharmacy Alerts, and Financial Messaging. Its Financial Messaging provides prescribers visibility to branded copay offers for patients directly within their electronic health record (EHR) systems and electronic prescribing (ERx) platforms. Its platform consists of a unified data intelligence technology stack, multiple cloud-based data warehouses, and in-house applications and application programming interface layers.
OPTIMIZERX CORP
260 Charles Street, Suite 302
Waltham MASSACHUSETTS 48307 US
CEO: William Febbo
Employees: 129
Phone: 12486516558
OptimizeRx Corp. is digital health company, engaged in the provision of digital health messaging via electronic health records, which serve as a direct channel for pharmaceutical companies to communicate with healthcare providers. The company is headquartered in Waltham, Massachusetts and currently employs 106 full-time employees. The company went IPO on 2005-05-18. The Company’s platform combines artificial intelligence (AI)-driven tools like the Dynamic Audience Activation Platform (DAAP) and Micro-Neighborhood Targeting (MNT) to deliver timely, relevant, and hyper-local engagement. Its DAAP generates dynamic audiences with predictive analytics via machine learning methods. MNT creates consumer audiences using a privacy-first process. Its principal solutions include Audience Development: DAAP and MNT, Audience Profiling: Profiler, Audience Activation and Media Execution, Pharmacy Alerts, and Financial Messaging. Its Financial Messaging provides prescribers visibility to branded copay offers for patients directly within their electronic health record (EHR) systems and electronic prescribing (ERx) platforms. Its platform consists of a unified data intelligence technology stack, multiple cloud-based data warehouses, and in-house applications and application programming interface layers.
The current stock price of OPRX is 8.63 USD. The price increased by 2.98% in the last trading session.
OPRX does not pay a dividend.
OPRX has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
The PE ratio for OPTIMIZERX CORP (OPRX) is 10.52. This is based on the reported non-GAAP earnings per share of 0.82 and the current share price of 8.63 USD.
OPTIMIZERX CORP (OPRX) has a market capitalization of 160.86M USD. This makes OPRX a Micro Cap stock.
OPTIMIZERX CORP (OPRX) will report earnings on 2026-03-05, after the market close.